St. Jude Medical, Inc. , a global medical device company, today announced a new multi-center clinical trial has found that using St. Jude Medical Fractional Flow Reserve technology changed the course of treatment for more than one fifth of patients suffering non-ST segment elevation myocardial infarction heart attacks.
from Content Keyword RSS http://ift.tt/1lu65Tj
via IFTTT
from Content Keyword RSS http://ift.tt/1lu65Tj
via IFTTT
No comments:
Post a Comment